KASSANDRA WILLIAMS: Open Payments
NPI 1992111629 · TECUMSEH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 18 payments from 9 companies in 2025. Trend: 2023 $364 · 2024 $458 · 2025 $436
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 3 | $113 |
| Sumitomo Pharma America, Inc. | 4 | $105 |
| Lilly USA, LLC | 4 | $86 |
| Organon LLC | 2 | $40 |
| PFIZER INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: ZURZUVAE, MOUNJARO, GEMTESA, MYFEMBREE, NEXPLANON, ABRYSVO, Cologuard Collection Kit, ZEPBOUND.
Industry payments across MI — which companies pay providers there.
